Details About Generic Salt ::  Amphoter

Main Medicine Class:: Anti-infective,antifungal   

(am-foe-TER-ih-sin B)
Amphotec
Class: Anti-infective/antifungal

 

Drugs Class ::

 Action Alters fungal cell membrane permeability.

Indications for Drugs ::

 Indications Treatment of invasive aspergillosis when renal impairment or unacceptable toxicity precludes use of amphotericin B deoxycholate and where prior amphotericin B deoxycholate therapy has failed.

Drug Dose ::

 Route/Dosage

ADULTS AND CHILDREN: Test dose: IV Infusion of small amount of final preparation (eg, 10 ml containing 1.6 to 8.3 mg) over 15 to 30 min and observe the patient carefully for 30 min. Initial dose: IV 3 to 4 mg/kg as required at a rate of 1 mg/kg/hr. Dose may be increased to 6 mg/kg if no improvement or there is evidence of progression of the fungal infection.

Contraindication ::

 Contraindications Hypersensitivity to amphotericin B, unless condition requiring treatment is life-threatening and amenable only to amphotericin B.

Drug Precautions ::

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Nephrotoxicity: Drug is toxic; use with caution under close supervision; however, amphotericin B frequently is the only effective treatment for potentially fatal fungal diseases.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CV: Hypotension; tachycardia; hypertension; arrhythmia; edema. CNS: Headache; confusion; depression; abnormal thinking. DERM: Sweating; rash; pruritus. EENT: Eye hemorrhage. GI: Nausea, vomiting; abdominal pain. GU: Increased creatinine; hematuria; kidney failure. HEMA: Thrombocytopenia. HEPA: Abnormal liver function tests; bilirubinemia. META: Hypokalemia; hypomagnesemia; hypocalcemia; hyperglycemia. RESP: Dyspnea; hypoxia; epistaxis, increased cough; hemoptysis; hyperventilation; apnea. OTHER: Chills; fever; pain; anaphylactoid reactions.

Drug Mode of Action ::  

 Action Alters fungal cell membrane permeability.

Drug Interactions ::

 Interactions

Antineoplastic agents: Enhanced potential for nephrotoxicity, bronchospasm and hypotension. Corticosteroids: Increased potential for hypokalemia. Cyclosporine, tacrolimus: May increase nephrotoxic effects. Flucytosine: Increased flucytosine toxicity. Nephrotoxic agents (eg, aminoglycosides): Possible synergistic nephrotoxicity. INCOMPATIBILITIES: Do not mix with other medications.

Drug Assesment ::

 Assessment/Interventions

  • Monitor patient closely during test administration for fever, chills, headache, nausea or vomiting.
  • Obtain patient history, including drug history and any allergies.
  • Ensure that fungal culture (blood or urine, as appropriate) of organism has been obtained before beginning therapy.
  • Monitor pulse and BP every 15 min during test dose.
  • Monitor IV injection site closely during administration for signs of infiltration.
  • Monitor laboratory values, including liver function tests, CBC, renal function tests, potassium and magnesium levels.
  • Monitor I&O during therapy.
  • Monitor temperature 4 hr after administration; may be elevated.
  • If patient experiences infusion-related symptoms (eg, chills, fever, hypotension, nausea), antihistamines and corticosteroids may be given before the infusion. Reducing the rate of infusion also may be helpful.
OVERDOSAGE: SIGNS & SYMPTOMS
  Cardio-respiratory arrest

Drug Storage/Management ::

 Administration/Storage

  • Reconstitute using only Sterile Water for Injection. Further dilution can be made with 5% Dextrose in water. Do not admix with saline or electrolytes or fluids containing preservatives.
  • Do not mix with any other drug. Administer through separate IV line or flush existing line with 5% dextrose in water.
  • Give test dose before full IV dose.
  • Administer full dose at 1 mg/kg/hr.
  • Administer IV form only to patients who are hospitalized or in an outpatient medical facility under close supervision.
  • Do not administer solutions that have precipitates or foreign matter.
  • Unopened vials can be stored at room temperature (59° to 86°F) until reconstituted.
  • Wear gloves during reconstitution and administration.
  • Reconstituted solutions can be stored under refrigeration (36° to 46°F) and used within 24 hr. Discard any unused solution.

Drug Notes ::

 Patient/Family Education

  • Explain need for prolonged therapy and for close monitoring during course of therapy.
  • Encourage patient to increase fluid intake to 2000 to 3000 ml/day if allowed.
  • Inform patient to report any discomfort at injection site immediately.
  • Instruct patient to report symptoms of chills, malaise, or fever.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.